Skip to main content
ADPT logo
ADPT
(NASDAQ)
Adaptive Biotechnologies Corporation
$22.31-- (--)
Loading... - Market loading

Adaptive Biotechnologies (ADPT) Stock Price & Financial Analysis

Adaptive Biotechnologies Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.95 - $22.91
52-Week High$23.15
52-Week Low$9.96
Open$21.95
Volume2.76M
Average Volume (3M)3.64M
Market Cap3.47B
Shares Outstanding155.52M
Price to Sales (P/S)11.75
Price to Book (P/B)16.04
EV/EBITDA-135.10
Revenue (TTM)295.41M
Net Income (TTM)-49.68M
Free Cash Flow (TTM)-29.54M
EPS (TTM)$-0.32
Profit Margin-16.82%
Operating Margin-15.82%
Return on Equity (ROE)-22.96%
Debt to Equity0.96
50-Day MA$18.04
200-Day MA$16.36
52-Week Change105.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Adaptive Biotechnologies

What is the current stock price for ADPT?

As of the latest trading session, ADPT stock trades at $22.31. The 52-week range is $9.96–$23.15, with a day range of $21.95–$22.91.

What is the P/E ratio for ADPT?

The P/E ratio (Price-to-Earnings) for ADPT is shown in the Key Statistics section. This valuation metric helps compare Adaptive Biotechnologies Corporation to industry peers.

Does ADPT pay dividends?

Adaptive Biotechnologies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADPT?

Based on 9 analysts, the consensus for ADPT is Buy.

What is the market cap of ADPT?

Adaptive Biotechnologies's market capitalization is $3.47B, classifying it as a mid-cap company. Adaptive Biotechnologies operates in the Healthcare sector within the Diagnostics & Research industry.